HEATHER HABERMAN: Open Payments
NPI 1649477068 · SAINT PAUL, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 59 payments from 13 companies in 2025. Trend: 2023 $1,605 · 2024 $1,784 · 2025 $1,417
Food & beverage: $1,180Education: $237
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $465 |
| Novartis Pharmaceuticals Corporation | 6 | $164 |
| PFIZER INC. | 11 | $139 |
| ABBVIE INC. | 5 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| GENZYME CORPORATION | 3 | $82 |
| Incyte Corporation | 3 | $73 |
| UCB, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, COSENTYX, CIBINQO, OPZELURA, Rhapsido, LIBTAYO.
Industry payments across MN — which companies pay providers there.
